A Patient with Glanzmann Thrombasthenia and Epistaxis Successfully Treated with Recombinant Factor Vila

• References

• 1 Petruson B. Epistaxis, a clinical study with special reference to fibrinolysis. Acta Otolaryngol 1974; (Suppl. 314) Suppl 34-36
• 2 Rodgers RCP, Levin J. A critical reappraisal of the bleeding time. Seminars in Thromb Haemost 1990; 16: 1-20
• 3 Mannucci P, Vicente V, Vianello L, Cattaneo M, Alberca I. et al Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time. Blood 1986; 67: 1148-1153
• 4 Hedner U. Experiences with recombinant factor Vila in haemophiliacs. In: Biotechnology of plasma proteins Albertini A, Lenfant CL, Mannucci PM, Sixma JJ. (eds) Curr Stud Hematol Blood Transf. Basel: Karger; 1991: 63-68
• 5 Kristensen J, Killander A, Hippe E, Helleberg C, Ellegard J. et al Clinical experience with recombinant factor Vila in patients with thrombocytopenia. Haemostasis 1996; (Suppl. 01) 26 Suppl 159-165
• 6 Ciavarella N, Schiavoni M, Valenzano E, Mangini F, Inchingolo F. Use of recombinant factor Vila (NovoSeven) in the treatment of two patients affected by type III von Willebrand’s disease with inhibitor undergoing oral surgery. Haemost 1996; 26 Suppl (Suppl. 01) 150-155